A brief survey of the recent ophthalmic literature underscores a resurgence of interest in indocyanine green angiography (ICGA). This cyanine dye (molecular weight 775) which is highly protein bound and does not readily escape from the choriocapillaris. There is a particularly efficient first pass effect in the liver; this limits the recirculation phenomenon which occurs with fluorescein angiography. Indocyanine green absorbs and reflects in the near infrared portion of the spectrum (805 nm and 835 nm, respectively). In this fashion, the retinal pigment epithelium (RPE) is essentially rendered invisible. These characteristics also facilitate visualisation of the choroid through haemorrhage or other pigmentary deposits in the retina or RPE. However, ICG has low fluorescence of only 4% when compared with the total fluorescence of fluorescein.4
PERSPECTIVE
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A brief survey of the recent ophthalmic literature underscores a resurgence of interest in indocyanine green angiography (ICGA). This imaging method may be particularly useful for the ophthalmologist, as it provides at least a theoretical advantage for improved imaging of the choroidal circulation when compared with fluorescein angiography. New temporal and spatial technological advances (that is, videoangiography and scanning laser ophthalmoscopy, respectively) are primarily responsible for this renewed interest. Thus, ICGA could become instrumental in elucidating the pathogenetic mechanisms of a variety of diseases processes, as well as serving as a diagnostic and therapeutic tool.
The flurry of recent publications on ICGA, particularly regarding age-related maculopathy (ARM), suggests a new standard of care for the management of patients with this disorder. However, its usefulness in the diagnosis and management of ARM and other disorders is as yet not entirely clear.
Physical properties
The physical and physiological properties of indocyanine green (ICG) were first described by Fox cyanine dye (molecular weight 775) which is highly protein bound and does not readily escape from the choriocapillaris. There is a particularly efficient first pass effect in the liver; this limits the recirculation phenomenon which occurs with fluorescein angiography. Indocyanine green absorbs and reflects in the near infrared portion of the spectrum (805 nm and 835 nm, respectively). In this fashion, the retinal pigment epithelium (RPE) is essentially rendered invisible. These characteristics also facilitate visualisation of the choroid through haemorrhage or other pigmentary deposits in the retina or RPE. However, ICG has low fluorescence of only 4% when compared with the total fluorescence of fluorescein.4
Early studies Initial interest and investigations with ICG and other vital dyes occurred during the 1970s. A substantial body of initial investigations of ICG was published by Flower and Hochheimer, as well as by others.4-9 Some of their initial work described a camera adapted with appropriate exciter and barrier filters such that simultaneous ICG and fluorescein angiography could be performed after a single injection of a combined mixture of ICG and fluorescein dyes. 6 The ICG dosage used in these initial absorption angiography studies tended to be similar to the amount used for cardiac flow studies -that is, 2 mg per kilogram body weight.' The early clinical investigators were uniformly disappointed in the lack of usefulness of ICGA in the confirmation of suspected choroidal neovascularisation.9-11 ICGA was not a useful guide to laser therapy of choroidal neovascularisation, but appeared to show particular promise in evaluation and monitoring growth of choroidal naevi and choroidal melanomas.9-11 In addition, investigators used this new modality to obtain insight into the normal and abnormal appearance of the choroidal circulation.9 11 12 These studies were limited in large part by inadequate photographic quality, the resolution of which did not allow visualisation of the choriocapillaris. Also, the motorised shutter cameras had a maximum frequency of exposure of one per 0-7 seconds (average choroidal transit time about 3 seconds). Attempts were made to adapt a 35 mm film camera to a fundus camera in order to improve the temporal resolution for study of the choroidal vascular circulation. '3 14 Further technical advances Recently, improved temporal and spatial resolution led to a renewed interest in ICGA. Tokoro and Hayashi were the first to report the use of the Topcon videoangiography system to improve temporal resolution, and other early clinical reports of ICG videoangiography followed. 15 This rate of conversion from occult to well defined CNV also was documented at the 40% level in two other independent studies.31 32 Pilot studies are under way regarding laser photocoagulation for occult CNV and recurrent occult CNV guided by ICGA findings.33 34 These results of laser photocoagulation must be considered preliminary as only historical controls are available for comparison regarding visual acuity outcome.
Guyer and co-workers have introduced new terminology into the study of ICGA in occult CNV in ARM -that is, focal CNV versus plaque CNV. Only further natural history studies will show whether this angiographic differentiation is clinically useful. 35 36 There is a higher correlation between documentation of CNV on FFA and on ICGA than originally reported; the latter publication documenting CNV site on FFA in 86% of their occult CNV series. 36 The presence of plaque CNV associated with ARM visualised by ICGA has been documented by a recent clinicopathological correlation. 37 The high rates of persistent CNV and recurrent CNV in ARM after laser photocoagulation limits a more favourable visual acuity outcome.38-4l ICGA has been proposed as a more effective means of judging adequacy of laser photocoagulation for CNV.42 Again, these results have not been reproduced in any controlled setting.
Other innovative developments may bring ICGA to the operating theatre to evaluate the effectiveness of surgical excision of subfoveal choroidal neovascularisation when compared with the preoperative ICGA. 43 Leakage of ICG dye into cystoid spaces within the retina in occult CNV associated with ARM has been documented.44 Detailed analyses of these images do not permit any conclusions regarding the pathway of ICG movement into these cystic spaces -that is, whether through an incompetent RPE or from overlying retinal vascular changes. Nevertheless, ICG dye in the neurosensory retina is a relative contraindication to diode enhanced laser photocoagulation.44
Central serous chorioretinopathy Perhaps one of the most exciting potential uses of ICG will be in the elucidation of the pathophysiology of various disease processes. While the clinical appearance and natural history of central serous chorioretinopathy (CSC) have been well described, the event which leads to the breakdown of the outer blood-retinal barrier is poorly understood.
Early comparison studies of FFA with ICGA features of CSC did not document any essential differences between these imaging methods. ' 
